Karuna Therapeutics is continuing to work with sites and sponsors to navigate through the COVID-19 outbreak. The STARR spoke with Steve Brannan, CMO of Karuna Therapeutics on what he is hearing on how the COVID-19 outbreak is impacting clinical trials.